7T MRI在多发性硬化中的应用:北美多发性硬化影像协作组的综述与共识声明
北美多发性硬化影像协作组(NAIMS)于2023年2月召开研讨会,回顾7T MRI在多发性硬化研究中的应用并形成共识声明。7T MRI有助于识别低场强MRI难以显示的多发性硬化病理特征,如灰质病灶、顺磁性边缘病灶、软脑膜强化和中央静脉征,并可用于研究脑代谢和功能改变。共识还就技术开发、通用采集协议及评估7T MRI对诊断、预后和治疗监测效用的研究提出了建议。
要点
- 7T MRI可识别灰质病灶、顺磁性边缘病灶、软脑膜强化和中央静脉征等低场强MRI难以显示的征象。
- NAIMS提出7T MRI的通用采集协议建议,供研究和临床推广应用。
- 共识声明涵盖技术开发方向及评估7T MRI对多发性硬化诊断、预后和治疗监测效用的研究建议。
核心结论
- 7T MRI在多发性硬化研究中具有识别和量化低场强MRI难以显示病理特征的潜力,NAIMS通过共识声明为其未来研究和临床转化提供路线图。
研究设计与样本
- NAIMS于2023年2月召开研讨会,专家回顾现有文献并提出系列共识声明,经NAIMS审核批准,形成本综述与共识文件。
关键影像表现/征象
- 7T MRI有助于识别和量化灰质病灶。
- 7T MRI有助于识别和量化顺磁性边缘病灶。
- 7T MRI有助于识别和量化软脑膜强化。
- 7T MRI有助于识别和量化中央静脉征。
- 7T MRI可用于研究多发性硬化脑代谢和功能改变。
临床应用与阅片要点
- NAIMS共识声明涉及7T MRI当前已知应用及未来加速研究和临床转化所需的工作。
- 共识提供技术开发指导、通用采集协议提案及评估7T MRI诊断、预后和治疗监测效用的研究建议。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The use of ultra-high-field 7-Tesla (7T) MRI in multiple sclerosis (MS) research has grown significantly over the past two decades. With recent regulatory approvals of 7T scanners for clinical use in 2017 and 2020, the use of this technology for routine care is poised to continue to increase in the coming years. In this context, the North American Imaging in MS Cooperative (NAIMS) convened a workshop in February 2023 to review the previous and current use of 7T technology for MS research and potential future research and clinical applications. In this workshop, experts were tasked with reviewing the current literature and proposing a series of consensus statements, which were reviewed and approved by the NAIMS. In this review and consensus paper, we provide background on the use of 7T MRI in MS research, highlighting this technology's promise for identification and quantification of aspects of MS pathology that are more difficult to visualize with lower-field MRI, such as grey matter lesions, paramagnetic rim lesions, leptomeningeal enhancement and the central vein sign. We also review the promise of 7T MRI to study metabolic and functional changes to the brain in MS. The NAIMS provides a series of consensus statements regarding what is currently known about the use of 7T MRI in MS, and additional statements intended to provide guidance as to what work is necessary going forward to accelerate 7T MRI research in MS and translate this technology for use in clinical practice and clinical trials. This includes guidance on technical development, proposals for a universal acquisition protocol and suggestions for research geared towards assessing the utility of 7T MRI to improve MS diagnostics, prognostics and therapeutic efficacy monitoring. The NAIMS expects that this article will provide a roadmap for future use of 7T MRI in MS.
引用
- Harrison DM, Sati P, Klawiter EC, et al. The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Brain Commun. 2024. PMID: 39445084. doi:10.1093/braincomms/fcae359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。